The Ninebot/AIMA share price ratio has failed to track the trend in the forward EPS ratios since mid-March 2023. The upcoming index outflow event could act as a catalyst for this ratio to dip.
Boomeranged on Wed, 25 Oct 2023 04:48
Final Expectations for the Dec 23 STAR 50 Rebalance: Sichuan Biokin Pharmaceutical (688506 CH) is an expected ADD and Ninebot (689009 CH) is an expected DEL. The SHORT Ninebot vs LONG AIMA Tech trade has started to move in the right direction and might be worth revisiting.